Evidence map›Paper›PMID 25888768›Full record

SynthesisWorld journal of surgical oncology2015

A systematic review and meta-analysis of the diagnostic accuracy of pyruvate kinase M2 isoenzymatic assay in diagnosing colorectal cancer.

Mallikarjuna Uppara, Franklin Adaba, Alan Askari, Susan Clark, George Hanna, Thanos Athanasiou, Omar Faiz

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in World journal of surgical oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 3 pooled it
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 3 syntheses or guidelines pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Review
  6. National cancer screening program for colorectal cancer in Korea.Annals of surgical treatment and research · 2023
    Review
  7. Article
  8. Review
  9. Novel Diagnostic Biomarkers in Colorectal Cancer.International journal of molecular sciences · 2022
    Review
  10. Review
  11. Article
  12. Pyruvate Kinase, Inflammation and Periodontal Disease.Pathogens (Basel, Switzerland) · 2021
    Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Colorectal Cancer and Metabolism.Current colorectal cancer reports · 2018
    Article
  18. Review
  19. Early detection: the impact of genomics.Virchows Archiv : an international journal of pathology · 2017
    Review
  20. Advances in Fecal Tests for Colorectal Cancer Screening.Current treatment options in gastroenterology · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Mallikarjuna UpparaSurgical Epidemiology, Trials and Outcome Centre (SETOC), St Mark's Hospital and Academic Institute, Harrow, Middlesex, HA1 3UJ, UK. drmallikarjuna@gmail.com.
Franklin AdabaDepartment of Surgery, St Mark's Hospital and Academic Institute, Harrow, Middlesex, HA1 3UJ, UK. uchiecoche@yahoo.co.uk.
Alan AskariSurgical Epidemiology, Trials and Outcome Centre (SETOC), St Mark's Hospital and Academic Institute, Harrow, Middlesex, HA1 3UJ, UK. alan.askari@gmail.com.
Susan ClarkDepartment of Surgery, St Mark's Hospital and Academic Institute, Harrow, Middlesex, HA1 3UJ, UK. s.clark8@nhs.net.
George HannaDepartment of Surgical Sciences, Imperial College, St Mary's Hospital, Praed Street, London, W21NY, UK. g.hanna@imperial.ac.uk.
Thanos AthanasiouDepartment of Cardiovascular Sciences and Cardiac Surgery, Imperial College, St Mary's Hospital, Praed Street, London, W21NY, UK. t.athanasiou@imperial.ac.uk.
Omar FaizSurgical Epidemiology, Trials and Outcome Centre (SETOC), St Mark's Hospital and Academic Institute, Harrow, Middlesex, HA1 3UJ, UK. o.faiz@imperial.ac.uk.
St Mark's Hospital · GBSt Mary's Hospital · GBLondon North West Healthcare NHS Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundScreening programmes exist in many countries for colorectal cancer. In recent years, there has been a drive for a non-invasive screening marker of higher sensitivity and specificity. Stool-based pyruvate kinase isoenzyme M2 (M2-PK) is one such biomarker under investigation. The aim of this systematic review and meta-analysis is to determine the diagnostic accuracy, sensitivity and specificity of M2-PK as a screening tool in colorectal cancer.

methodsA literature search of Ovid Medline, EMBASE and Google Scholar was carried out. The search strategy was restricted to human subjects and studies published in English. Data on sensitivity and specificity were extracted and pooled. Statistical analysis was conducted using summary receiver operating characteristic (SROC) curve methodology.

resultsA total of eight studies were suitable for data synthesis and analysis. Our analysis showed a pooled sensitivity and specificity for M2-PK to be 79% (CI 73%-83%) and 80% (CI 73%-86%), respectively. The accuracy of M2-PK was 0.85(0.82-0.88).

conclusionFaecal M2-PK assay has a relatively good sensitivity and specificity and high accuracy for screening colorectal cancer.

Indexed as

Early Detection of CancerBiological AssayCase-Control StudiesColorectal NeoplasmsHumansPrognosisPyruvate KinasePyruvate Kinase

Identifiers

PMID25888768
PMCPMC4333243
OpenAlexW2128033725

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.